- How different is the once-weekly teriparatide from the daily one or the same?
-
Takeuchia
- KMID: 2463602
- Osteoporos Sarcopenia.
- 2019 Jun;5(2):27-28.
- doi: 10.1016/j.afos.2019.06.004
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Change of the Halo Sign and the Grafted Bone according to the Usage of Teriparatide for the Correction Loss due to Screw Loosening after Corrective Osteotomy
-
Park YS, Kim JH, Lee CH
- KMID: 2391938
- J Rheum Dis.
- 2011 Jun;18(2):114-117.
Among osteoporosis medications, Teriparatide is an agent that promotes bone formation and it seems to have an effect, due to an anabolic mechanism, in the early postoperative period after osteosynthesis... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of radius bone densitometry for the treatment of osteoporosis with once-weekly teriparatide therapy
-
Nakayama H, Toho H, Sone T
- KMID: 2437857
- Osteoporos Sarcopenia.
- 2018 Mar;4(1):29-32.
- doi: 10.1016/j.afos.2018.02.001
OBJECTIVES: As clinics that treat patients with osteoporosis do not usually have central dual-energy X-ray absorptiometry (DXA), bone density is often measured with radial DXA. However, no long-term evidence exists... -
- CITED
-
- Close
- SHARE
-
- Close
- Unusual Excessive Callus Formation in the Intertrochanteric Fracture Treated with Teriparatide
-
Shin YS, Jung HJ, Savale AP, Han SB
- KMID: 2054161
- Hip Pelvis.
- 2014 Mar;26(1):41-44.
- doi: 10.5371/hp.2014.26.1.41
This is the first case report on the effects of teriparatide on the course of healing of an intertrochanteric hip fracture with unusually excessive callus formation even after discontinuation of... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Severe Hypercalcemia after Treatment with Teriparatide for Osteoporosis
-
Koo JW, Lee JH, Jang NE, Kim H, Seok HY, So YR, Shin AR, Cho JH, Lee SH
- KMID: 1464236
- Korean J Bone Metab.
- 2012 May;19(1):53-58.
- doi: 10.11005/kjbm.2012.19.1.53
Recombinant human parathyroid hormone 1-34 (rHPTH; 1-34, teriparatide) increases bone mass and increases osteoporotic fracture by stimulating new bone formation. It was approved in the United States for treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Weekly Teriparatide Therapy Rapidly Accelerates Bone Healing in Pyogenic Spondylitis with Severe Osteoporosis
-
Shinohara , Ueno Y, Marumo K
- KMID: 2270311
- Asian Spine J.
- 2014 Aug;8(4):498-501.
- doi: 10.4184/asj.2014.8.4.498
Pyogenic spondylitis is a frequently observed disease in orthopedics, and the number of cases is increasing. Some patients with pyogenic spondylitis suffer from vertebral destruction due to infection. The disease... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Intractable Bisphosphonate-Related Osteonecrosis of the Jaw Treated with Teriparatide
-
Lee S, Huh JH, Kim WJ, Kim KM, Cha IH, Rhee Y
- KMID: 2314119
- Osteoporosis.
- 2012 Aug;10(2):76-81.
Bisphosphonates are the most widely used medications for treating high bone turnover osteoporosis, Paget's disease of bone, multiple myeloma and metastatic carcinomas, etc. However, a destructive complication of bisphosphonate-related osteonecrosis... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Teriparatide in Women with Osteoporosis after Lumbar Posterolateral Fusion or Posterior Lumbar Interbody Fusion
-
Seo JH, Lee KY, Kim MW
- KMID: 2068925
- J Korean Soc Spine Surg.
- 2015 Sep;22(3):82-91.
- doi: 10.4184/jkss.2015.22.3.82
STUDY DESIGN: Retrospective study. OBJECTIVES: To investigate radiologic and clinical outcomes of teriparatide in women with osteoporosis after instrumented lumbar posterolateral fusion (PLF) or posterior lumbar interbody fusion (PLIF). SUMMARY OF LITERATURE... -
- CITED
-
- Close
- SHARE
-
- Close
- Atypical Femoral Fractures: What Do We Know about Them?
-
Lee BS, Lee YK, Won H, Kim H, Koo KH
- KMID: 2422898
- J Korean Fract Soc.
- 2018 Oct;31(4):159-164.
- doi: 10.12671/jkfs.2018.31.4.159
Recently, atypical femoral fractures (AFFs) have been found in patients who were prescribed bisphosphonate to prevent osteoporotic fractures. Although the occurrence of AFF is rare, there are some concerns, such... -
- CITED
-
- Close
- SHARE
-
- Close
- One Case of Primary Hyperparathyroidism Diagnosed with Hypercalcemia after using Teriparatide
-
Kim DH, Kim JW, Park JH, Sung JM, Kim HY, Kim JM
- KMID: 2314157
- Osteoporosis.
- 2015 Aug;13(1):55-59.
- doi: 10.0000/ost.2015.13.1.55
Primary hyperparathyroidism is a disease that causes hypercalcemia and abnormal bone metabolism due to an increase in parathyroid hormones, and the occurrence rate of bone fracturing is higher in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Can Three Months of Teriparatide Be One of Treatment Options for Osteoporotic Vertebral Compression Fracture Patients?
-
Kang JH, Yang SM, Im SB, Jeong JH
- KMID: 2444201
- Korean J Neurotrauma.
- 2019 Apr;15(1):19-27.
- doi: 10.13004/kjnt.2019.15.e13
OBJECTIVE: Osteoporosis is one of the most common causes of vertebral compression fractures (VCFs). Teriparatide, a recombinant human parathyroid hormone, is the first anabolic agent for the treatment of osteoporosis.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Teriparatide on Pregnancy-Induced Osteoporosis
-
Lee SH, Hong MK, Park SW, Park HM, Kim J, Ahn J
- KMID: 2286303
- J Bone Metab.
- 2013 Nov;20(2):111-114.
- doi: 10.11005/jbm.2013.20.2.111
Pregnancy-induced osteoporosis is a rare disorder characterized by fragility fracture and low bone mineral density (BMD) during or shortly after pregnancy, and its etiology is still unclear. We experienced a... -
- CITED
-
- Close
- SHARE
-
- Close
- Bone Mineral Density and Bone Turnover Markers after One-year Teriparatide Treatment in Korean Postmenopausal Women with Osteoporosis
-
Park SY, Bae JH, Kim JY, Oh HJ, Joo IW
- KMID: 2189023
- J Korean Soc Osteoporos.
- 2010 Apr;8(1):56-63.
OBJECTIVES: Recombinant teriparatide, a bone anabolic agent, is known to result in a net positive bone balance and reduce vertebral and nonvertebral fracture incidence. The objective of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis?
-
Ohtori S, Orita S, Yamauchi K, Eguchi Y, Aoki Y, Nakamura J, Suzuki M, Kubota G, Inage K, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Inoue M, Kinoshita , Furuya T, Koda M
- KMID: 2377761
- Asian Spine J.
- 2017 Apr;11(2):272-277.
- doi: 10.4184/asj.2017.11.2.272
STUDY DESIGN: Retrospective case series. PURPOSE: The purpose of this study was to determine whether discontinuing teriparatide treatment and replacing it with bisphosphonate treatment maintains the volume of the fusion mass... -
- CITED
-
- Close
- SHARE
-
- Close
- Post Pregnancy Severe Spinal Osteoporosis with Multiple Vertebral Fractures and Kyphoscoliosis in a Multigravida: A Rare Case with Management
-
Hadgaonkar S, Shah KC, Bhatt H, Shyam A, Sancheti P
- KMID: 2169338
- Asian Spine J.
- 2015 Aug;9(4):625-628.
- doi: 10.4184/asj.2015.9.4.625
Osteoporosis associated with pregnancy and lactation is a less commonly known condition and often overlooked. The prevalence, exact aetiology and its pathogenesis are unknown. It is commonly seen in first... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Osteoporosis: Unmet Needs and Emerging Solutions
-
Langdahl B, Andersen J
- KMID: 2419840
- J Bone Metab.
- 2018 Aug;25(3):133-140.
- doi: 10.11005/jbm.2018.25.3.133
Efficient therapies are available for the treatment of osteoporosis, however, there are still unmet needs. Anti-resorptive therapies only increase bone mineral density to a certain extent and reduce the risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
-
Shin CJ, Kim S, Choi CS, Shin HC, Kwon YJ
- KMID: 2356785
- Korean J Neurotrauma.
- 2016 Oct;12(2):123-127.
- doi: 10.13004/kjnt.2016.12.2.123
OBJECTIVE: Bisphosphonate, a typical bone resorption inhibitor, is an important first-line drug for treating osteoporosis. Recent studies show a novel paradigm in stimulating bone formation. Teriparatide, which is composed of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Teriparatide on Healing of Atypical Femoral Fractures: A Systemic Review
-
Im GI, Lee SH
- KMID: 2170126
- J Bone Metab.
- 2015 Nov;22(4):183-189.
- doi: 10.11005/jbm.2015.22.4.183
BACKGROUND: Bisphosphonates (BPs) are the most commonly used anti-osteoporotic drugs, which have been proven to reduce the risk of osteoporotic fractures. However, use of BPs, particularly for long periods of... -
- CITED
-
- Close
- SHARE
-
- Close
- More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery
-
Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kuniyoshi , Aoki Y, Nakamura J, Miyagi M, Suzuki M, Kubota G, Inage K, Sainoh T, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Inoue G, Takahashi
- KMID: 2169329
- Asian Spine J.
- 2015 Aug;9(4):573-580.
- doi: 10.4184/asj.2015.9.4.573
STUDY DESIGN: Retrospective case series. PURPOSE: To examine the most effective duration of teriparatide use for spinal fusion in women with postmenopausal osteoporosis. OVERVIEW OF LITERATURE: We reported that daily subcutaneous injection... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review
-
Kim SM, Kang KC, Kim JW, Lim SJ, Hahn MH
- KMID: 2371834
- J Bone Metab.
- 2017 Feb;24(1):65-73.
- doi: 10.11005/jbm.2017.24.1.65
BACKGROUND: The use of osteoanabolic agents to facilitate fracture healing has been of heightened interest to the field of orthopaedic trauma. This study aimed to evaluate the evidence of teriparatide... -
- CITED
-
- Close
- SHARE
-
- Close
